Crestor Lawyers - Side Effects, Recall, Lawsuit
Crestor Claims Question? Get Answer, Free.
  HOME   ABOUT US   CRESTOR RESOURCES   FAQ's CRESTOR NEWS CONTACT US September 6, 2010
Small Business Lawyers Image
 
 
Selecting an attorney for your legal case is a very important decision. Please enter a zip code to find an attorney in your area:
 
  More Product Liability
 

Privacy Policy

This notice outlines the privacy policies of the Site. By visiting this website, and/or submitting any information on any of the forms linked to this Privacy Policy you are accepting the practices described herein.
You must be at least 18 years old to use our Sites. We do not knowingly collect, use or disclose Personal Information about visitors under 18 years of age. If you are the parent or guardian of a minor under 18 years of age and believe that such minor has disclosed Personal Information to us, please contact us at cs@moxymedia.com so that we may delete the minor's information from our database.

1.0          How we collect information

1.1          User IP Address

Each time a user visits the Site, our web server automatically recognizes the user’s IP address and the Web page from which the User came. The User’s IP address is used to help identify the User and to gather broad demographic information about the User. We also use IP addresses collected to help diagnose problems with our servers, to administer the Sites, and to better serve users in using the services and features of the Sites.

1.2          Cookies and Action Tags

The first time a user provides an e-mail address in connection with their activities at a Site, we assign an identification number to that e-mail address and deploy a cookie to the user's PC. Whenever that user comes back to a Site using the same PC, the cookie allows the Site to identify the user and to recall the user's e-mail address. If, at any time, a user provides other information in connection with their activities on a Site (such as name, address, birth date, gender, etc.), we may store that information, along with the users e-mail address, in our user database. We may use the information stored in our database (i) for the purpose for which the information was originally provided by a user; (ii) to pre-populate information fields in the event a user wishes to sign up for and/or subscribe to services, promotions or offers in the future; (iii) to ensure that a user will not be repeatedly exposed to the same ads, offers and promotions while visiting Sites; and (iv) to, in connection with regular communication with a user, include offers, promotions or advertisements historically, or likely to be, of interest to that user.
Action Tags, Web Beacons and other Data Collection Methods: An action tag or a web-beacon (also known as a clear gif or a pixel tag) is a method used to track responses or actions by visitors who view certain advertisements or other information on a site. Action tags are 1x1 pixel images embedded in a website page that are used to transparently collect information. We may use action tags to count the number of times that visitors click on a particular banner ad or visit the pages of our Sites and to provide information about what products are viewed or purchased.

1.3          Personal Information

By registering with, or providing personal information to a Site, as well as providing permission to receive marketing offers, Users allow us, our affiliates, partners and certain approved third parties to make their personally identifiable information available to third parties in accordance with the terms of this privacy policy and the privacy policy of the respective affiliated sites. While on a Site we may collect “Personal Information” from a user.  For the purposes of this Privacy Policy, Personal Information shall mean individually identifiable information from or about an individual including, but not limited to: (a) a first and last name; (b) a home or other physical address, including street name and name of city or town; (c) an e-mail address or other online contact information, such as an instant messaging user identifier or a screen name that reveals and individual’s e-mail address; (d) a telephone number; (e) a Social Security number; (f) a persistent identifier, such as a customer number held in a cookie or processor serial number, that is combined with other available data that identifies and individual; (g) age; (h) income level; (i) hobbies, buying patterns or preferences; or (j) any other information from or about an individual that is combined with any of (a) through (j) above.

2.0          How We Use Personal Information

Information collected may be transmitted to our approved advertising and marketing partners, our affiliated companies, or certain other approved third parties interested in providing users with information or services that you may request or for other marketing and promotional purposes. Requested information or information regarding site updates, new products and services, upcoming events and/or status of any requests or orders may be provided to users by e-mail, postal mail, telephone SMS text-messaging or by any other means of contact that users may provide. We may also use Personal Information for customer service, to provide information that a user may request, to customize a user’s experience on a Site, and to contact a user when necessary in connection with transactions entered into by that user on a Site. We may also use personal information for internal business purposes, such as analyzing and managing our business. We may also combine the information we have gathered about users with information from other sources. We may use third parties to help us operate our business and the Sites or administer activities on our behalf.
By entering your SSN into the website, users consent to allow us to share their SSN with certain approved outside service providers for evaluation of user’s applications and provision of loan services.
By providing a telephone number users agree and specifically thereby request that we, our partners, associates and/or certain approved third parties may contact you via such telephone number whether or not such number may be included in any State, Federal or other Do Not Call Registry.
We and/or our marketing partners and affiliated companies enhance and/or merge Personal Information about users with data collected from other sources to use in direct and/or online marketing.
We reserve the right, in connection with a transfer of any of our assets to any affiliated company, to provide Personal Information and data to the affiliate subject to the terms of this policy. Similarly, we reserve the right, in connection with a sale of any of our assets or businesses to a third party, to sell our database containing Personal Information, or any relevant portion thereof. We may release Personal Information as we determine may be required by law, to enforce any terms of service, or to protect the rights, property or safety of our Sites, its registered users, or others. Please note that our privacy policy does not apply to websites or web pages that link to our Sites.
You may, at any time, notify us that you do not wish to have your Personal Information disclosed to third parties for offers and promotions by sending an e-mail to cs@moxymedia.com.

3.0          How We Use Demographic Information

We use demographic information to tailor Sites to the interests of our users. Demographic information is shared with advertisers so that they can tailor their advertisements to the appropriate audience. Demographic information may also be shared with other third parties.

4.0          Other Sites

Other sites accessible through our Sites have their own privacy policies and data collection, use and disclosure practices. Please consult each site's privacy policy. We are not responsible for the policies or practices of third parties. Please be aware that our Sites may contain links to other sites on the Internet that are owned and operated by third parties. The information practices of those websites linked to our Sites are not covered by this Privacy Policy. These other sites may send their own cookies to users, collect data, or solicit Personal Information. Additionally, other companies that place advertising on our Sites may collect information about you when you view or click on their advertising through the use of cookies. We cannot control this collection of information. You should contact these advertisers directly if you have any questions about their use of the information that they collect.
On behalf of various sponsors, we may provide sponsored links to third-party websites. If you click on a sponsored link or banner ad, a "window" or "frame" containing a third-party's web site may appear in the foreground with a Site in the background. Unless you are on one of our Sites, any time that you have moved to a window, you should assume that your Personal Information is being collected, used and disclosed in accordance with the windowed site's privacy policy (if any). If you are unsure as to whose privacy policy applies, please contact us by e-mail at cs@moxymedia.com.

5.0          Our Security Precautions

The Site has security measures in place to protect against the loss, misuse and alteration of the information under our control. We encrypt all of your personal and financial information and use our best efforts to prevent it from being read or intercepted as the information travels over the Internet. While we are committed to protecting your information, we cannot ensure or warrant the security of any information you transmit to us.

6.0          Removal of Your Information/Opting Out

At your request, we will remove Personal Information that users have provided to us from our database. Users may make such request by e-mailing cs@moxymedia.com. However, deleting Personal Information or otherwise opting-out of receipt of communications from us or third parties will only change or delete the data in our database for purposes of transacting future business on a Site and for managing future communications from us and third parties. These deletions will not change or delete Personal Information already collected as part of a particular transaction in our database, which may have already been shared with third parties, all as provided above in this Privacy Policy. Users may need to contact third parties who may contact you directly in order to change the preferences for the use of personal information that they may have or use.

We provide users the option to opt-out from receiving information sent via electronic mailings on behalf of third party advertisers. Users may unsubscribe from receiving e-mails at any time by following the instructions contained at the end of every e-mailing. Unsubscribe requests can only be processed if you have registered with us in the first instance. If you have not registered with us and wish to opt out of receiving e-mails from a particular sender, please consult that sender’s opt out policies or contact that sender directly.
Information sent on behalf of third party advertisers is prepared several days in advance, so users may continue to receive e-mail from us for up to 5 days after following the unsubscribe procedures detailed above. If after that point a user is still receiving email from us, the user should contact us at cs@moxymedia.com.

7.0 Limitation of Damages

IN NO EVENT SHALL WE BE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING FROM YOUR USE OF A SITE OR FOR THE UNAUTHORIZED MODIFICATION OF TEXT OR ADVERTISEMENTS PROVIDED BY US TO OUR MARKETING PARTNERS OR THIRD PARTIES.
DISCLAIMER - THE SERVICE IS PROVIDED "AS IS" AND WITHOUT WARRANTIES OF ANY KIND EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMISSIBLE PURSUANT TO APPLICABLE LAW, WE DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WE DO NOT WARRANT THAT THE FUNCTIONS EXPLAINED IN SITE WILL BE UNINTERRUPTED OR ERROR-FREE, THAT DEFECTS WILL BE CORRECTED, OR THAT THIS SITE IS FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. WE DO NOT WARRANT OR MAKE ANY REPRESENTATIONS REGARDING THE USE OR THE RESULTS OF THE USE OF THE MATERIALS IN THIS SITE OR AS MAY BE PROVIDED IN RESPONSE TO YOUR INQUIRY IN TERMS OF THEIR CORRECTNESS, ACCURACY, RELIABILITY, OR OTHERWISE. USER ASSUMES THE ENTIRE COST OF ALL NECESSARY SERVICING, REPAIR, OR CORRECTION. APPLICABLE LAW MAY NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU.

LIMITATION OF LIABILITY - UNDER NO CIRCUMSTANCES, INCLUDING, BUT NOT LIMITED TO, NEGLIGENCE, SHALL WE BE LIABLE FOR ANY SPECIAL OR CONSEQUENTIAL DAMAGES THAT RESULT FROM THE USE OF, OR THE INABILITY TO USE THE MATERIALS IN THIS SITE OR ANY INFORMATION PROVIDED TO YOU IN RESPONSE TO YOUR INQUIRY, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. APPLICABLE LAW MAY NOT ALLOW THE LIMITATION OR EXCLUSION OF LIABILITY OR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SO THE ABOVE LIMITATION OR EXCLUSION MAY NOT APPLY TO YOU. IN NO EVENT SHALL OUR TOTAL LIABILITY TO YOU FOR ALL DAMAGES, LOSSES, AND CAUSES OF ACTION (WHETHER IN CONTRACT, TORT (INCLUDING BUT NOT LIMITED TO, NEGLIGENCE), OR OTHERWISE) EXCEED THE AMOUNT PAID BY YOU, IF ANY, FOR ACCESSING THIS SITE.

8.0          Changes to the Privacy Policy

We reserve the right to change the terms of this Privacy Policy. Since any changes will be posted on this page, we encourage you to check this page regularly.  Any changes to this policy shall be effective immediately upon posting them here.  This privacy policy was last amended on March 29, 2007.

9.0          Contacting us about privacy questions or concerns

If you have any questions about this Privacy Policy, the practices of a Site, or your dealings with this Site, please email us at cs@moxymedia.com, or by sending a letter to:

Moxy Media
100 Cypress Creek Rd. Ste 1050
Fort Lauderdale, FL 33309

 
Latest Crestor News
 
FDA Cannot Ignore Warnings on Crestor
house.gov, Jan 24, 2007
He also identified Crestor as one of five drugs on the market that he believed posed serious safety concerns that should have been further investigated....
Read more >

FDA Approves First Generic Pravastatin
fda.gov, Dec 27, 2006
Pravastatin is indicated for the treatment of individuals with high cholesterol levels (hyperlipidemia) or who are at increased risk for atherosclerosis-related...
Read more >

Statin Users Risk Heart Attacks By Stopping Treatment
healthfinder.gov, Dec 11, 2006
People with high cholesterol levels who stop taking the drugs called statins increase their risk of heart attacks by at least 30 percent, a Dutch study finds....
Read more >

Some Drugs From Canadian Web Sites Fake: FDA
healthfinder.gov, Nov 27, 2006
A number of prescription drugs ordered from 10 Web sites linked to a Canadian pharmacy were fake, according to tests by the U.S. Food and Drug Administration....
Read more >

Elderly Patients Discontinue Use Of Cholesterol-Lowering Drugs
ahrq.gov, Nov 13, 2006
The researchers studied statin use among 34,501 elderly patients enrolled in the New Jersey Medicaid ...
Read more >

Hispanics Benefit From Cholesterol-Lowering Statins Like Crestor
healthfinder.gov, Oct 19, 2006
CRP is a marker of inflammation, and high levels of CRP correlate with increased risk of coronary heart disease....
Read more >

Alert For Healthcare Professionals Regarding Crestor
fda.gov, Oct 05, 2006
Some individuals taking Crestor will experience muscle side effects, most commonly mild aches and very rarely severe muscle damage...
Read more >

Fake Crestor Sold On Canadian Web Sites
womenshealth.gov, Sep 21, 2006
Even though the drugs seized by the FDA were ordered from Canada-based Mediplan, the drugs were not shipped from Canada, the AP reported...
Read more >

Aggressive Statin Therapy May Reverse Atherosclerosis
womenshealth.gov, Aug 10, 2006
Intensive cholesterol-lowering therapy using Crestor not only reduced LDL or bad cholesterol levels but actually reversed atherosclerosis...
Read more >

Abbott and AstraZeneca to Develop Crestor and TriCor Combo
Press Release, Jul 27, 2006
Abbott and AstraZeneca announced today a collaboration to co-develop and market a combination treatment that will target all three important blood lipids ...
Read more >

FDA Alert On Rosuvastatin Calcium, Marketed As Crestor
Enter Source, Jun 22, 2006
...
Read more >

This Five Year Crestor Study Will Evaluate The Drug
4woman.gov, May 24, 2006
You must be taking Crestor and be a male over age 50 or a female over age 60...
Read more >

FDA Crestor Alert
fda.gov, Apr 27, 2006
Asian patients compared with a Caucasian control group that found drug levels to be elevated approximately ...
Read more >

Crestor Dosage
fda.gov, Mar 17, 2006
The 40mg dose of CRESTOR is reserved only for those patients who have not achieved their LDL C goal utilizing ...
Read more >

Crestor Warning On Pregnancy And Lactation
www.fda.gov, Mar 01, 2006
Rosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards...
Read more >

FDA Updated Safety Information For Crestor
accessdata.fda.gov, Feb 15, 2006
In treating Asian Americans, since a large pharmacokinetic study found that this group of patients had drug levels about twice as high as a Caucasian control group...
Read more >

Renal Week Debates On Drugs And The Kidney Damage Symptoms
Press Release, Jan 31, 2006
Public Citizen, a public interest organization headquartered in Washington, DC, petitioned the FDA to remove Crestor from the market...
Read more >

Crestor Drug Warning
energycommerce.house.gov, Jan 16, 2006
are the signals for the potential progression to renal failure in a small number of patients, this may represent an unacceptable risk since currently approved statins do ...
Read more >

FDA Alert On Crestor
FDA.Gov, Jan 02, 2006
Crestor is being revised to highlight important information on the safe use of Crestor to reduce the risk for serious muscle toxicity ...
Read more >

Center For Drug Evaluation On Crestor Medication
FDA.gov, Dec 01, 2005
FDA is also making statements about the muscle and kidney safety of Crestor ...
Read more >

FDA News Information Concerning Crestor
fda.gov, Nov 22, 2005
FDA is providing up-to-date information about the risk of serious muscle damage in patients ...
Read more >

Cholesterol Drug Crestor Produces More Side Effects
healthfinder.gov, Nov 14, 2005
The FDA denied the group's request, but required the drug to carry a revised warning label to emphasize the risk of muscle damage...
Read more >

FDA Public Health Advisory on Crestor
fda.gov, Oct 17, 2005
Ongoing controlled clinical trials of Crestor and other statins, epidemiologic studies....
Read more >

Updated Patient and Healthcare Provider Information Concerning Crestor
fda.gov, Sep 09, 2005
Agency Effort to Provide Public with Early Access to Emerging Safety Information ...
Read more >

Crestor Has A Much Lower Rate
healthfinder.gov, Aug 16, 2005
Crestor Has A Much Lower Rate Of Adverse Side Effects Than Baycol...
Read more >

Synthetic Lipid-Lowering Agent
accessdata.fda.gov, Aug 09, 2005
Rosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase...
Read more >

Reported In Patients Taking Crestor As Well As Other Statin Drugs
fda.gov, Aug 05, 2005
Rhabdomyolysis (serious muscle damage) has been reported in patients taking Crestor as well as other statin drugs....
Read more >

Crestor Is A Drug That Comes Under The Umbrella
ryar.org, Jul 13, 2005
Crestor Is A Drug That Comes Under The Umbrella Of ‘Statins’ And Is Prescribed For Cholesterol Reduction...
Read more >

Unfortunately Create Unnecessary Alarm
fda.gov, Jun 23, 2005
CRESTOR Are Misleading, And Unfortunately Create Unnecessary Alarm For Patients Who Need This Medication...
Read more >

Crestor A Member Of A Class Of Cholesterol Lowering Drugs
FDA, May 20, 2005
Crestor, a member of a class of cholesterol-lowering drugs commonly referred to as “statins”, was approved in the U.S....
Read more >

Rosuvastatin Calcium Marketed as Crestor Information
FDA, May 13, 2005
Rosuvastatin Calcium Marketed as Crestor Information...
Read more >

FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor
FDA, May 05, 2005
FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor...
Read more >

FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor
FDA, Apr 27, 2005
Part of an Ongoing Agency Effort to Provide Public with Early Access to Emerging Safety Information In order to provide Americans with earlier access ...
Read more >

Medtronic Announces Additional Devices Affected in Voluntary Recall of Certain Monophasic LifePak 500 Automated External Defibrillators
FDA, Apr 25, 2005
Medtronic Announces Additional Devices Affected in Voluntary Recall of Certain Monophasic LifePak 500 Automated External Defibrillators...
Read more >

FDA Rejects Public Citizen's Petition for AstraZeneca's CRESTOR(R)
biz.yahoo, Mar 30, 2005
U.S. Food and Drug Administration (FDA) has formally denied Public Citizen's Health Research Group's (HRG) petition to remove CRESTOR...
Read more >

Citizen's Health Research Group's (HRG) Petition To Remove CRESTOR(R) (Rosuvastatin Calcium) From The Market
fda, Mar 16, 2005
The U.S. (FDA) Has Formally Denied Public Citizen's Health Research Group's (HRG) Petition To Remove CRESTOR(R) (Rosuvastatin Calcium) From The Market...
Read more >

The Crestor“Warnings” And “Dosage And Administration” Sections Of The Label Have Been Revised To More Strongly
fda gov, Mar 15, 2005
The Crestor“Warnings” And “Dosage And Administration” Sections Of The Label Have Been Revised To More Strongly Emphasize The Risks Of Myopathy, Particularly At The Highes...
Read more >

Mercy Hospital Foundation Receives $50,000 Donation Through the CRESTOR(R) Charity Challenge at PGA TOUR's
all mericanpatriots, Mar 08, 2005
For Phil Mickelson's performance, CRESTOR, an AstraZeneca pharmaceutical product, and the Ford Championship at Doral, will donate $50,000 to the Mercy Hospital Foundation...
Read more >

FDA issues Health Advisory on Crestor
FDA, Mar 02, 2005
Astra-Zeneca Pharmaceuticals today released a revised package insert for Crestor ...
Read more >

FDA Admonishes Crestor Manufacturer Over Ads
Press release, Feb 14, 2005
FDA Sends AstraZeneca Letter Regarding Crestor Advertisements...
Read more >

Crestor (rosuvastatin): New Warning Label
Federal Gov Article, Feb 04, 2005
Crestor Announces New Method Of Warning Consumers...
Read more >

FDA Public Health Advisory for Crestor (rosuvastatin)
FDA Article, Jan 27, 2005
Astra-Zeneca Pharmaceuticals today released a revised package insert for Crestor (rosuvastatin) for use in the 22 member states of the European Union (EU). ...
Read more >

VA Study on Cholesterol Drug May Protect Vision
Veterans Health Administration, Nov 24, 2004
Elderly men who take cholesterol-lowering drugs known as statins are less likely to develop age-related macular degeneration...
Read more >

Cholesterol-Lowering Statins May Protect Against Colorectal Cancer
nci.nih.gov, Nov 24, 2004
Drugs taken by millions of Americans to lower cholesterol may also reduce the risk of colorectal cancer, a new study suggests....
Read more >

Keeping Cholesterol Under Control
fda.gov, Nov 23, 2004
The body needs cholesterol for digesting dietary fats, making hormones, building cell walls, and other important processes. ...
Read more >

Fatty cholesterol deposits raising the risk of heart disease.
fda.gov, Nov 23, 2004
One of the main ways blood cholesterol can reach undesirable levels is through a diet high in saturated fat and cholesterol. ...
Read more >

Public Citizen's Petition to Remove Crestor From the Market
Public Citizen, Oct 29, 2004
Petition Letter to the FDA from the Public Citizen Health Research Director, Sidney M. Wolfe, MD to remove Crestor from the market....
Read more >

Patients in the Dark About Cholesterol Drug Recall
Public Citizen, Oct 31, 2002
FDA Needs Statutory Authority to Order and Enforce Recalls; Drug Industry Should Pay for Patient Notification, Consumer Advocate Says...
Read more >

Milwaukee Golf Charities Receives $50,000 Donation
Enter Source, Jan 01, 1900
Milwaukee Golf Charities Receives $50,000 Donation Through The CRESTOR(R) Charity Challenge At PGA Tour's...
Read more >

More Crestor-Related News>


 
Regional Resources
 
Search for Crestor-related resources in your State:

Alabama
Missouri
Alaska Montana
Arizona Nebraska
Arkansas Nevada
California New Hampshire
Colorado New Jersey
Connecticut New Mexico
DC New York
Delaware North Carolina
Florida North Dakota
Georgia Ohio
Hawaii Oklahoma
Idaho Oregon
Illinois Pennsylvania
Indiana Rhode Island
Iowa South Carolina
Kansas South Dakota
Kentucky Tennessee
Lousiana Texas
Maine Utah
Maryland Vermont
Mass Virginia
Michigan Washington
Minnesota West Virginia
Mississippi Wisconsin
  Wyoming

Browse Map >
 
     
 
Crestor Hot Topics
 
Crestor Warning
Kidney Failure, Muscle Damage & Crestor
Crestor Drug Information
FDA: Crestor Health Advisory

Crestor May Be Pulled
Petition to Remove Crestor US Drug Disaster History
What is Hyperlipidemia
FDA: 2003 Crestor Approval

 
  Crestor Resources  
 


Crestor Facts & Information
Crestor Drug Info (PDF)
Crestor Links
Crestor Audio & Videos
The US Federal Code
Crestor Laws

More Crestor Resources >

 
  Did You Know?  
   
 
 


Legal Disclaimers

All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on Crestor Recalls.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Your access to and use of this website is subject to additional Terms and Conditions.

Local Professional? Generate new business today
Call 866-227-9356 or contact a sales rep


This site is part of the LawFirms.com Network
©2010 ExpertHub, wholly owned subsidiary of MoxyMedia, Inc.